Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
27 Oct 2026T-MAXIMUM Pharmaceutical IncUnited States, TaiwanThe METAMAX Study: MT027 Allogeneic CAR-T for Brain Metastases From Advanced Solid TumorsPhase 2Not Yet Recruiting26 Oct 2026BioligentUnited StatesA Clinical Trial to Evaluate the Effects of Adrenal Adapt on Sleep Quality, Daytime Energy, Stress Resilience, and Cognitive Performance.Not applicableRecruiting26 Oct 2026Hiya HealthUnited StatesA Clinical Trial to Evaluate the Effects of a Children's Daily Multivitamin on Perceived Growth, Immune Health, Energy, and Focus in ChildrenNot applicableRecruiting26 Oct 2026Jubaan Ltd.United StatesEvaluation of Gixam's Repeatability and Reproducibility Predicting the Presence of Advanced and Non-Advanced Colorectal NeoplasiaNot applicableNot Yet Recruiting26 Oct 2026MNnutraUnited StatesA Study to Evaluate the Effects of a Dietary Supplement on Weight Management and Appetite ControlNot applicableActive Not Recruiting26 Oct 2026NeuEveUnited StatesA Clinical Trial to Evaluate the Effects of the NeuEve Dryness Treatment Kit on Vaginal Health, Comfort, and Quality of Life in Postmenopausal WomenNot applicableNot Yet Recruiting26 Oct 2026SanofiUnited StatesA Study to Describe Patient REal-world FitusiRan ExpeRienceNot Yet Recruiting23 Oct 2026Ancestral Supplements, LLCUnited StatesA Study to Evaluate the Effects of a Beef Liver Supplement on Energy, Mood, and Mental ClarityNot applicableActive Not Recruiting23 Oct 2026Ascletis Pharma (China) Co., LimitedUnited StatesA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or OverweightPhase 1Recruiting23 Oct 2026Ascletis Pharma (China) Co., LimitedUnited StatesA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or OverweightPhase 1Recruiting23 Oct 2026Hikma Pharmaceuticals USA Inc.United StatesPharmacokinetics and Safety of a Single Dose of Epinephrine Nasal Spray in Paediatric Allergy PatientsPhase 2Not Yet Recruiting23 Oct 2026NutromicsUnited StatesVancomycin Exposure and Biomarker Tracking Using Real-time Monitoring of Interstitial FluidNot Yet Recruiting23 Oct 2026SalivIQ Diagnostics, Inc.United StatesA Multicenter Evaluation of SalivIQ™ Strep A for Detecting Group A Streptococcus From Saliva and Throat Swabs in Patients With Acute PharyngitisRecruiting23 Oct 2026Sonavex, Inc.United StatesStudy of 3D Ultrasound for Support of Hemodialysis CannulationNot applicableRecruiting22 Oct 2026Akita Biosciences, Inc.United StatesFeasibility, Acceptability, and Safety of a Drug-Free Nasal Spray in Frontline Healthcare WorkersNot applicableCompleted22 Oct 2026Aktis Oncology, Inc.United StatesA Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid TumorsPhase 1Recruiting22 Oct 2026Bavarian NordicUnited StatesPhase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young AdultsPhase 1Not Yet Recruiting22 Oct 2026Eli Lilly and CompanyUnited States, ArgentinaA Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 DiabetesPhase 2Not Yet Recruiting22 Oct 2026EvolvUnited StatesA Controlled Study to Evaluate the Effects of a Supplement on Weight Loss, Blood Sugar, and Appetite SuppressionNot applicableCompleted22 Oct 2026Lipocosm, LLCUnited StatesA Study to Evaluate the Benefits of Harmonic Vibration LiposuctionActive Not Recruiting22 Oct 2026Pathalys PharmaUnited StatesA Study of PLS240 in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisPhase 3Not Yet Recruiting22 Oct 2026Therabody, Inc.United StatesEfficacy of an LED MaskNot applicableEnrolling By Invitation22 Oct 2026Vertex Pharmaceuticals IncorporatedUnited StatesA Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled SyringePhase 3Recruiting21 Oct 2026Bristol-Myers SquibbUnited StatesA Phase 1 Study to Evaluate Safety, Tolerability, and Drug Levels of BMS-986485 in Healthy Adult ParticipantsPhase 1Not Yet Recruiting21 Oct 2026Clinical Nutrition Research Center, Illinois Institute of TechnologyUnited StatesDifferential Absorption Kinetics of Grape Seed Extract PolyphenolsNot applicableNot Yet Recruiting21 Oct 2026Clinical Nutrition Research Center, Illinois Institute of TechnologyUnited StatesEffects of Mango on Insulin Sensitivity in PrediabetesNot applicableNot Yet Recruiting21 Oct 2026Ethyreal Bio, Inc.United StatesEvaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye DiseasePhase 1Recruiting21 Oct 2026GRIN Therapeutics, Inc.United StatesA Study to Evaluate the Effect of Carbamazepine or Itraconazole on Radiprodil in Healthy Adult ParticipantsPhase 1Active Not Recruiting21 Oct 2026Imagion Biosystems, Inc.United StatesMagSense® Human Epidermal Growth Factor Receptor 2 (HER2) Imaging Agent (MSH2IA)Phase 1, Phase 2Recruiting21 Oct 2026InnSight Technology, Inc.United StatesCorneal Trauma Diagnostic StudyNot applicableRecruiting21 Oct 2026IRulya Therapeutics Inc.United StatesLAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)Phase 2Not Yet Recruiting21 Oct 2026KingdomUnited StatesA Fifth Proof-of-Concept Study to Evaluate the Efficacy of NOBO, a Novel Postbiotic, in Controlling Axillary Odor in Healthy AdultsNot applicableActive Not Recruiting21 Oct 2026Tarsus Pharmaceuticals, Inc.United States, Dominican Republic, El SalvadorA Study to Evaluate the Efficacy and Safety of TP-06 for PCEDPhase 2Recruiting21 Oct 2026UNCANCER LLCUnited StatesOral Care Program for Mouth Side Effects During Head and Neck Radiation TherapyNot applicableRecruiting20 Oct 2026Dignify TherapeuticsUnited StatesA Single Ascending Dose Study of DTI-117 Given Intramuscularly in Healthy Participants.Phase 1Recruiting20 Oct 2026Eli Lilly and CompanyUnited States, SingaporeA Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 DiabetesPhase 1Recruiting20 Oct 2026Eli Lilly and CompanyUnited States, CanadaA Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).Phase 1Not Yet Recruiting20 Oct 2026ModernaTX, Inc.United StatesA Study of Updated mRNA Seasonal Influenza VaccinesPhase 4Recruiting20 Oct 2026Necternal LLCUnited StatesA Clinical Study to Evaluate the Effects of a Supplement on Cognitive FunctionNot applicableActive Not Recruiting20 Oct 2026PepsiCo Global R&DUnited StatesA Descriptive Analysis of the Physiological and Behavioral Profiles of Elite Female AthletesEnrolling By Invitation20 Oct 2026Philips Digital & Computational PathologyUnited StatesThis Study is the Clinical Validation Study for Validation for the Digital Pathology System 'SGi 1.0 + EPW 1.0 + Compatible Clinical Displays'Recruiting20 Oct 2026Verrica Pharmaceuticals Inc.United StatesSafety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)Phase 2Not Yet Recruiting// How AOS uses this